Insider holders · CIK 0000891293
CTI BIOPHARMA CORP · CTIC
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| OrbiMed Capital GP VI LLC10% Owner | — | 5,000,000 | 5,000,000 | Jun 15, 2017 · 5:40 pm EDT | Form 4 |
| ORBIMED ADVISORS LLC10% Owner | — | 5,000,000 | 5,000,000 | Jun 15, 2017 · 5:40 pm EDT | Form 4 |
| Samuel D Isaly10% Owner | — | 5,000,000 | 5,000,000 | Jun 15, 2017 · 5:40 pm EDT | Form 4 |
| James A BiancoPresident and CEO | 1,780,133 | — | 1,780,133 | Jun 24, 2016 · 6:16 pm EDT | Form 4 |
| BVF Partners OS Ltd.relationship not stated | 483,708 | 1,295,582 | 1,779,290 | Feb 12, 2018 · 9:59 pm EST | Form 4 |
| Biotechnology Value Trading Fund OS LPrelationship not stated | 483,708 | 1,295,582 | 1,779,290 | Feb 12, 2018 · 9:59 pm EST | Form 4 |
| Mark N Lampert10% Owner | 483,708 | 1,295,582 | 1,779,290 | Feb 12, 2018 · 9:59 pm EST | Form 4 |
| BIOTECHNOLOGY VALUE FUND II LPrelationship not stated | 483,708 | 1,295,582 | 1,779,290 | Feb 12, 2018 · 9:59 pm EST | Form 4 |
| Inc/il Bvf10% Owner | 483,708 | 1,295,582 | 1,779,290 | Feb 12, 2018 · 9:59 pm EST | Form 4 |
| BVF PARTNERS L P/IL10% Owner | 483,708 | 1,295,582 | 1,779,290 | Feb 12, 2018 · 9:59 pm EST | Form 4 |
| BIOTECHNOLOGY VALUE FUND L Prelationship not stated | 483,708 | 1,295,582 | 1,779,290 | Feb 12, 2018 · 9:59 pm EST | Form 4 |
| Jack W SingerEVP, Chief Scientific Officer | 994,057 | — | 994,057 | Mar 23, 2016 · 6:27 pm EDT | Form 4 |
| Louis A BiancoEVP, Finance & Administration | 622,933 | 37 | 622,970 | Mar 23, 2016 · 6:36 pm EDT | Form 4 |
| Matthew PlunkettEVP, Chief Business Officer | 526,210 | — | 526,210 | Mar 23, 2016 · 6:47 pm EDT | Form 4 |
| Mary Oneil MundingerDirector | 360,019 | — | 360,019 | Apr 29, 2016 · 5:45 pm EDT | Form 4 |
| Reed Vaughn TucksonDirector | 92,424 | — | 92,424 | May 2, 2017 · 5:45 pm EDT | Form 4 |
| Fred TellingDirector | 78,874 | — | 78,874 | May 2, 2017 · 5:46 pm EDT | Form 4 |
| Richard L LoveDirector | 73,718 | — | 73,718 | Oct 2, 2017 · 5:25 pm EDT | Form 4 |
| Phillip M Nudelman Ph.D.Director | 73,129 | — | 73,129 | May 2, 2017 · 5:46 pm EDT | Form 4 |
| Matthew D PerryDirector | 43,139 | — | 43,139 | May 21, 2018 · 7:01 pm EDT | Form 4 |
| Bruce J. SeeleyEVP, Chief Operating Officer | 32,000 | — | 32,000 | Jan 3, 2019 · 4:31 pm EST | Form 4 |
| Michael A MetzgerDirector | 20,121 | — | 20,121 | Jan 22, 2018 · 6:28 pm EST | Form 4 |
| Baxter Healthcare SA10% Owner | 0 | — | 0 | May 1, 2015 · 5:23 pm EDT | Form 4 |
| David Ross ParkinsonDirector | 0 | — | 0 | Jun 7, 2017 · 6:13 pm EDT | Form 3 |
| Laurent FischerDirector | 0 | — | 0 | Jul 25, 2017 · 5:08 pm EDT | Form 3 |
| Adam R CraigSee Remarks | 0 | — | 0 | Mar 21, 2017 · 7:07 pm EDT | Form 3 |
| David KirskeSee Remarks | 0 | — | 0 | Aug 3, 2017 · 7:01 pm EDT | Form 3 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.